FDA.reportPublic FDA data

resmetirom 100 MG Oral Tablet

RxCUI
2677899
RxNorm name
resmetirom 100 MG Oral Tablet
Display name
resmetirom 100 MG Oral Tablet
Full name
resmetirom 100 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
REZDIFFRARESMETIROMMadrigal Pharmaceuticals, Inc.e67ea09f-a840-439c-86c8-f98585f978b22026-07-29Warnings, Adverse reactionsExact identifier
rxcui: 2677899

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e67ea09f-a840-439c-86c8-f98585f978b2resmetirom 100 MG Oral Tablet [PSN] · resmetirom 100 MG Oral Tablet [SCD] · resmetirom 100 MG Oral Tablet [SY]33These highlights do not include all the information needed to use REZDIFFRA safely and effectively. See full prescribing information for REZDIFFRA. REZDIFFRA (resmetirom) tablets, for oral use Initial U.S. Approval: 202420251222